Evidence map›Paper›PMID 37690356›Full record

ArticleBiosensors & bioelectronics2023

Multi-modal sensing with integrated machine learning to differentiate specific leukocytes targeted by electrically sensitive hybrid particles.

Brandon K Ashley, Jianye Sui, Mehdi Javanmard, Umer Hassan

Open access · greenAbstract read
In one paragraph

Article in Biosensors & bioelectronics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Brandon K AshleyDepartment of Biomedical Engineering, Rutgers, the State University of New Jersey, Piscataway, NJ, 08854, USA.
Jianye SuiDepartment of Electrical and Computer Engineering, Rutgers, the State University of New Jersey, Piscataway, NJ, 08854, USA.
Mehdi JavanmardDepartment of Biomedical Engineering, Rutgers, the State University of New Jersey, Piscataway, NJ, 08854, USA; Department of Electrical and Computer Engineering, Rutgers, the State University of New Jersey, Piscataway, NJ, 08854, USA.
Umer HassanDepartment of Biomedical Engineering, Rutgers, the State University of New Jersey, Piscataway, NJ, 08854, USA; Department of Electrical and Computer Engineering, Rutgers, the State University of New Jersey, Piscataway, NJ, 08854, USA; Global Health Institute, Rutgers, the State University of New Jersey, New Brunswick, NJ, 08901, USA. Electronic address: umer.hassan@rutgers.edu.
Rutgers, The State University of New Jersey · US

Funding

Rutgers Biotechnology Training ProgramT32GM135141 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI ANN M. STOCK, Martin L Yarmush · 2020 to 2026
$3.5M
NIGMS NIH HHS T32 GM135141
6 · The paper itself

Abstract

The growing need for personalized, accurate, and non-invasive diagnostic technology has resulted in significant advancements, from pushing current mechanistic limitations to innovative modality developments across various disease-related biomarkers. However, there still lacks clinical solutions for analyzing multiple biomarkers simultaneously, limiting prognosis for patients suffering with complicated diseases or comorbidities. Here, we conceived, fabricated, and validated a multifrequency impedance cytometry apparatus with novel frequency-sensitive barcoded metal oxide Janus particles (MOJPs) as cell-receptor targeting agents. These microparticles are modulated by a metal oxide semi-coating which exhibit electrical property changes in a multifrequency electric field and are functionalized to target CD11b and CD66b membrane proteins on neutrophils. A multi-modal system utilizing supervised machine learning and simultaneous high-speed video microscopy classifies immune-specific surface receptors targeted by MOJPs as they form neutrophil-MOJP conjugates, based on multivariate multifrequency electrical recordings. High precision and sensitivity were determined based on the type of MOJPs conjugated with cells (>90% accuracy between neutrophil-MOJP conjugates versus cells alone). Remarkably, the design could differentiate the number of MOJPs conjugated per cell within the same MOJP class (>80% accuracy); which also improved comparing electrical responses across different MOJP types (>75% accuracy) as well. Such trends were consistent in individual blood samples and comparing consolidated data across multiple samples, demonstrating design robustness. The configuration may further expand to include more MOJP types targeting critical biomarker receptors in one sample and increase the modality's multiplexing potential.

Indexed as

Biosensing TechniquesBiomarkersElectric ImpedanceHumansLeukocytesMachine LearningOxidesBiomarkersOxidesBiomarkersBiosensorDisease diagnosticsImpedance cytometryMachine learningMicrofluidics

Identifiers

PMID37690356
PMCPMC10977608
OpenAlexW4386401782

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.